Loading...
Chemical structure of GSK778

GC62654

GSK778

Also known as 4-[2-(methoxymethyl)-1-[(1R)-1-phenylethyl]-8-[[(3S)-pyrrolidin-3-yl]methoxy]imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole

GSK778 (iBET-BD1) is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively

ChemicalCAS2451862-42-1MW511.61FormulaC30H33N5O3
CAS number
2451862-42-1
Molecular weight
511.61
Formula
C30H33N5O3
Solubility
DMSO : 41·67 mg/mL (81·45 mM; Need ultrasonic)
InChIKey
ZORLJXWXFABTPZ-CTNGQTDRSA-N
Catalogue number
GC62654
Brand
GLPBIO
Computed properties PubChem CID 146018691 · XLogP 4.2 · TPSA 87.2 Ų · H-bond donors 1
XLogP
4.2
TPSA
87.2 Ų
H-bond donors
1
H-bond acceptors
7
Rotatable bonds
8
Heavy atoms
38

SMILES CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=N4)COC)[C@H](C)C5=CC=CC=C5)OC[C@H]6CCNC6

Computed descriptors from PubChem (CID 146018691), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.